ATE448218T1 - Chemisches verfahren - Google Patents

Chemisches verfahren

Info

Publication number: ATE448218T1
Authority: AT; Austria
Prior art keywords: chemical process; chemical
Prior art date: 2005-09-30

Application number

AT06794582T

Other languages

English (en)

Inventor

Joergen Blixt

Michael Golden

Philip Hogan

David Martin

Francis Montgomery

Zakariya Patel

John Pittam

George Sependa

Christopher Squire

Nicholas Wright

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-09-30

Filing date

2006-09-27

Publication date

2009-11-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35395001&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE448218(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-09-27 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2009-11-15 Application granted granted Critical

2009-11-15 Publication of ATE448218T1 publication Critical patent/ATE448218T1/de

Links

238000001311 chemical methods and process Methods 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT06794582T 2005-09-30 2006-09-27 Chemisches verfahren ATE448218T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0519879.1A GB0519879D0 (en)	2005-09-30	2005-09-30	Chemical process
PCT/GB2006/003587 WO2007036713A2 (en)	2005-09-30	2006-09-27	Chemical process

Publications (1)

Publication Number	Publication Date
ATE448218T1 true ATE448218T1 (de)	2009-11-15

Family

ID=35395001

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT06794582T ATE448218T1 (de)	2005-09-30	2006-09-27	Chemisches verfahren
AT09152654T ATE481399T1 (de)	2005-09-30	2006-09-27	Verfahren zur in-situ chemischer sulfonierung

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AT09152654T ATE481399T1 (de)	2005-09-30	2006-09-27	Verfahren zur in-situ chemischer sulfonierung

Country Status (31)

Country	Link
US (8)	US8163926B2 (de)
EP (2)	EP2053048B8 (de)
JP (2)	JP5213715B2 (de)
KR (1)	KR101307641B1 (de)
CN (3)	CN102503898B (de)
AR (1)	AR055671A1 (de)
AT (2)	ATE448218T1 (de)
AU (1)	AU2006296367B2 (de)
BR (1)	BRPI0616715A2 (de)
CA (2)	CA2745829C (de)
CY (2)	CY1110275T1 (de)
DE (2)	DE602006010428D1 (de)
DK (2)	DK1943240T3 (de)
ES (2)	ES2335435T3 (de)
GB (1)	GB0519879D0 (de)
HR (2)	HRP20100019T1 (de)
IL (2)	IL190172A (de)
ME (2)	ME01531B (de)
MY (2)	MY149834A (de)
NO (1)	NO342152B1 (de)
NZ (2)	NZ566566A (de)
PL (2)	PL2053048T3 (de)
PT (2)	PT1943240E (de)
RS (2)	RS51263B (de)
RU (1)	RU2448102C2 (de)
SG (1)	SG165416A1 (de)
SI (2)	SI2053048T1 (de)
TW (2)	TWI424991B (de)
UY (1)	UY29824A1 (de)
WO (1)	WO2007036713A2 (de)
ZA (1)	ZA200802416B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2365588C2 (ru) *	2002-02-01	2009-08-27	Астразенека Аб	Хиназолиновые соединения
GB0519879D0 (en) *	2005-09-30	2005-11-09	Astrazeneca Ab	Chemical process
CL2007003158A1 (es) *	2006-11-02	2008-05-16	Astrazeneca Ab	Procedimiento de preparacion de compuestos derivados de quinazolina o sus sales farmaceuticamente aceptables; compuestos intermediarios; procedimiento de preparacion.
EP2404595B1 (de) *	2011-09-01	2015-08-05	Symrise AG	Verfahren zur Herstellung von Indanon-Derivaten
ES2678697T3 (es) *	2012-08-15	2018-08-16	Glaxo Group Limited	Proceso químico
CN104098544A (zh) *	2013-04-07	2014-10-15	浙江九洲药物科技有限公司	一种凡德他尼的制备方法
CN106397401B (zh) *	2016-08-30	2018-11-13	山东罗欣药业集团股份有限公司	一种抗癌药物的晶体化合物及其制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4870083A (en)	1987-11-24	1989-09-26	Merrell Dow Pharmaceuticals Inc.	1,4-Disubstituted-piperidinyl compounds useful as analgesics and muscle relaxants
JP2829744B2 (ja)	1989-05-31	1998-12-02	川研ファインケミカル株式会社	ピペリジンカルボン酸類の製造方法
WO1992006086A1 (en)	1990-10-01	1992-04-16	Janssen Pharmaceutica N.V.	Novel 4-piperidinylcarbonyl derivatives
JP2659107B2 (ja)	1991-03-28	1997-09-30	エーザイ株式会社	複素環式―環式アミン誘導体
US5710158A (en)	1991-05-10	1998-01-20	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
DK0584222T3 (da)	1991-05-10	1998-02-23	Rhone Poulenc Rorer Int	Bis-mono- og bicycliske aryl- og heteroarylforbindelser, som inhiberer EGF- og/eller PDGF-receptor-tyrosinkinase
US5624926A (en)	1993-02-18	1997-04-29	Kyowa Hakko Kogyo Co., Ltd.	Piperidinyl-dioxoquinazolines as adenosine reuptake inhibitors
ES2121210T3 (es) *	1993-05-26	1998-11-16	Syntex Inc	Nuevos ligandos de receptores 5-ht4 a base de 1-fenilalcan-1-onas.
DE4326344A1 (de)	1993-08-05	1995-02-09	Thomae Gmbh Dr K	Carbonamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
WO1995019344A1 (en)	1994-01-13	1995-07-20	Merck Sharp & Dohme Limited	Gem-disubstituted azacyclic tachykinin antagonists
GB9624482D0 (en)	1995-12-18	1997-01-15	Zeneca Phaema S A	Chemical compounds
CN1116286C (zh)	1996-03-05	2003-07-30	曾尼卡有限公司	4－苯胺基喹唑啉衍生物
CA2265630A1 (en)	1996-09-13	1998-03-19	Gerald Mcmahon	Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders
GB9718972D0 (en) *	1996-09-25	1997-11-12	Zeneca Ltd	Chemical compounds
EP1676845B1 (de) *	1999-11-05	2008-06-11	AstraZeneca AB	Neue Quinazolin-Derivate
GB0126879D0 (en)	2001-11-08	2002-01-02	Astrazeneca Ab	Combination therapy
EP1467995B1 (de)	2001-12-20	2010-05-19	OSI Pharmaceuticals, Inc.	Pyrrolopyrimidin a2b selektive antagonistische verbindungen, deren synthese und verwendung
RU2365588C2 (ru)	2002-02-01	2009-08-27	Астразенека Аб	Хиназолиновые соединения
AU2003207291A1 (en)	2002-02-06	2003-09-02	Ube Industries, Ltd.	Process for producing 4-aminoquinazoline compound
GB0218526D0 (en)	2002-08-09	2002-09-18	Astrazeneca Ab	Combination therapy
EP1534287A1 (de)	2002-08-09	2005-06-01	Astrazeneca AB	Kombination von zd6474, einem inhibitor des vaskulären endothelialen wachstumsfaktorrezeptors, mit radiotherapie für die behandlung von krebs
GB0223380D0 (en)	2002-10-09	2002-11-13	Astrazeneca Ab	Combination therapy
SI1592423T1 (sl)	2003-02-13	2011-07-29	Astrazeneca Ab	Kombinacijska terapija ZD6474 s 5-FU in/ali CPT-11
WO2005004870A1 (en)	2003-07-10	2005-01-20	Astrazeneca Ab	Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
GB0318423D0 (en)	2003-08-06	2003-09-10	Astrazeneca Ab	Chemical compounds
GB0519879D0 (en) *	2005-09-30	2005-11-09	Astrazeneca Ab	Chemical process

2005
- 2005-09-30 GB GBGB0519879.1A patent/GB0519879D0/en not_active Ceased
2006
- 2006-09-27 AU AU2006296367A patent/AU2006296367B2/en not_active Ceased
- 2006-09-27 ES ES06794582T patent/ES2335435T3/es active Active
- 2006-09-27 CA CA2745829A patent/CA2745829C/en not_active Expired - Fee Related
- 2006-09-27 DE DE602006010428T patent/DE602006010428D1/de active Active
- 2006-09-27 DE DE602006017004T patent/DE602006017004D1/de active Active
- 2006-09-27 AT AT06794582T patent/ATE448218T1/de active
- 2006-09-27 HR HR20100019T patent/HRP20100019T1/hr unknown
- 2006-09-27 SG SG201006940-9A patent/SG165416A1/en unknown
- 2006-09-27 EP EP09152654A patent/EP2053048B8/de active Active
- 2006-09-27 MY MYPI2011003076A patent/MY149834A/en unknown
- 2006-09-27 PT PT06794582T patent/PT1943240E/pt unknown
- 2006-09-27 CN CN201110159729.XA patent/CN102503898B/zh active Active
- 2006-09-27 AT AT09152654T patent/ATE481399T1/de active
- 2006-09-27 RU RU2008116573/04A patent/RU2448102C2/ru not_active IP Right Cessation
- 2006-09-27 ES ES09152654T patent/ES2350513T3/es active Active
- 2006-09-27 NZ NZ566566A patent/NZ566566A/en not_active IP Right Cessation
- 2006-09-27 NZ NZ593930A patent/NZ593930A/xx not_active IP Right Cessation
- 2006-09-27 ME MEP-2013-51A patent/ME01531B/me unknown
- 2006-09-27 US US12/088,680 patent/US8163926B2/en active Active
- 2006-09-27 PL PL09152654T patent/PL2053048T3/pl unknown
- 2006-09-27 SI SI200630816T patent/SI2053048T1/sl unknown
- 2006-09-27 WO PCT/GB2006/003587 patent/WO2007036713A2/en not_active Ceased
- 2006-09-27 PL PL06794582T patent/PL1943240T3/pl unknown
- 2006-09-27 PT PT09152654T patent/PT2053048E/pt unknown
- 2006-09-27 DK DK06794582.4T patent/DK1943240T3/da active
- 2006-09-27 DK DK09152654.1T patent/DK2053048T3/da active
- 2006-09-27 KR KR1020087009317A patent/KR101307641B1/ko not_active Expired - Fee Related
- 2006-09-27 RS RSP-2010/0037A patent/RS51263B/sr unknown
- 2006-09-27 JP JP2008532864A patent/JP5213715B2/ja not_active Expired - Fee Related
- 2006-09-27 ME MEP-2013-21A patent/ME01466B/me unknown
- 2006-09-27 MY MYPI20080855A patent/MY145540A/en unknown
- 2006-09-27 CN CN201110159628.2A patent/CN102503933B/zh active Active
- 2006-09-27 CN CN200680036468XA patent/CN101277948B/zh active Active
- 2006-09-27 CA CA2624045A patent/CA2624045C/en not_active Expired - Fee Related
- 2006-09-27 RS RSP-2010/0520A patent/RS51515B/sr unknown
- 2006-09-27 EP EP06794582A patent/EP1943240B1/de active Active
- 2006-09-27 BR BRPI0616715-2A patent/BRPI0616715A2/pt not_active IP Right Cessation
- 2006-09-27 SI SI200630524T patent/SI1943240T1/sl unknown
- 2006-09-29 TW TW099102690A patent/TWI424991B/zh not_active IP Right Cessation
- 2006-09-29 UY UY29824A patent/UY29824A1/es unknown
- 2006-09-29 AR ARP060104320A patent/AR055671A1/es not_active Application Discontinuation
- 2006-09-29 TW TW095136340A patent/TWI328580B/zh not_active IP Right Cessation
2008
- 2008-03-11 NO NO20081267A patent/NO342152B1/no not_active IP Right Cessation
- 2008-03-13 IL IL190172A patent/IL190172A/en not_active IP Right Cessation
- 2008-03-14 ZA ZA200802416A patent/ZA200802416B/xx unknown
2010
- 2010-01-25 CY CY20101100076T patent/CY1110275T1/el unknown
- 2010-11-12 CY CY20101101019T patent/CY1110887T1/el unknown
- 2010-11-16 HR HR20100620T patent/HRP20100620T1/hr unknown
2011
- 2011-12-07 US US13/314,034 patent/US8865899B2/en active Active
2012
- 2012-11-28 JP JP2012259782A patent/JP5654546B2/ja not_active Expired - Fee Related
2013
- 2013-07-21 IL IL227574A patent/IL227574A/en not_active IP Right Cessation
2014
- 2014-09-09 US US14/481,302 patent/US20140378684A1/en not_active Abandoned
2015
- 2015-07-22 US US14/805,816 patent/US9815816B2/en active Active
2017
- 2017-10-27 US US15/796,615 patent/US10344015B2/en active Active
2019
- 2019-05-08 US US16/406,246 patent/US20190263782A1/en not_active Abandoned
2020
- 2020-11-02 US US17/086,666 patent/US20220033377A1/en not_active Abandoned
2023
- 2023-03-07 US US18/118,549 patent/US20240150317A1/en not_active Abandoned

Also Published As

Publication number	Publication date
TWI328580B (en)	2010-08-11
DE602006017004D1 (de)	2010-10-28
CA2624045A1 (en)	2007-04-05
CN102503898B (zh)	2015-03-25
PT1943240E (pt)	2010-01-11
NO20081267L (no)	2008-04-30
IL227574A (en)	2015-08-31
DK1943240T3 (da)	2010-03-01
CN101277948A (zh)	2008-10-01
JP2013063998A (ja)	2013-04-11
RS51515B (sr)	2011-06-30
US9815816B2 (en)	2017-11-14
EP2053048A1 (de)	2009-04-29
ES2335435T3 (es)	2010-03-26
AR055671A1 (es)	2007-08-29
RS51263B (sr)	2010-12-31
CN102503898A (zh)	2012-06-20
CN102503933B (zh)	2014-06-25
US20190263782A1 (en)	2019-08-29
DK2053048T3 (da)	2010-11-29
US20120095229A1 (en)	2012-04-19
CA2624045C (en)	2012-05-22
WO2007036713A2 (en)	2007-04-05
CA2745829A1 (en)	2007-04-05
US8163926B2 (en)	2012-04-24
NZ566566A (en)	2011-08-26
CN101277948B (zh)	2013-03-13
PT2053048E (pt)	2010-11-10
HK1122553A1 (en)	2009-05-22
EP2053048B1 (de)	2010-09-15
EP1943240B1 (de)	2009-11-11
GB0519879D0 (en)	2005-11-09
US20240150317A1 (en)	2024-05-09
SI1943240T1 (sl)	2010-02-26
PL2053048T3 (pl)	2011-03-31
NO342152B1 (no)	2018-04-03
US10344015B2 (en)	2019-07-09
CN102503933A (zh)	2012-06-20
EP2053048B8 (de)	2011-09-21
JP5213715B2 (ja)	2013-06-19
CY1110275T1 (el)	2015-01-14
UY29824A1 (es)	2007-04-30
US20160185754A1 (en)	2016-06-30
ME01466B (me)	2014-04-20
HK1130478A1 (en)	2009-12-31
RU2448102C2 (ru)	2012-04-20
JP5654546B2 (ja)	2015-01-14
JP2009510039A (ja)	2009-03-12
HRP20100019T1 (hr)	2010-02-28
EP1943240A2 (de)	2008-07-16
SI2053048T1 (sl)	2010-12-31
ME01531B (me)	2014-04-20
US20140378684A1 (en)	2014-12-25
ATE481399T1 (de)	2010-10-15
MY145540A (en)	2012-02-29
US20220033377A1 (en)	2022-02-03
WO2007036713A3 (en)	2007-06-14
IL190172A0 (en)	2008-08-07
US8865899B2 (en)	2014-10-21
HRP20100620T1 (hr)	2010-12-31
US20180118716A1 (en)	2018-05-03
CA2745829C (en)	2013-07-02
BRPI0616715A2 (pt)	2011-06-28
NZ593930A (en)	2013-02-22
DE602006010428D1 (de)	2009-12-24
AU2006296367A1 (en)	2007-04-05
TWI424991B (zh)	2014-02-01
RU2008116573A (ru)	2009-11-10
TW200745036A (en)	2007-12-16
US20090203905A1 (en)	2009-08-13
KR20080049114A (ko)	2008-06-03
SG165416A1 (en)	2010-10-28
ES2350513T3 (es)	2011-01-24
TW201018660A (en)	2010-05-16
IL190172A (en)	2014-05-28
MY149834A (en)	2013-10-31
ZA200802416B (en)	2009-01-28
AU2006296367B2 (en)	2011-08-11
CY1110887T1 (el)	2015-06-10
PL1943240T3 (pl)	2010-04-30
KR101307641B1 (ko)	2013-09-12

Legal Events

Date

Code

Title

Description

2010-05-15

UEP

Publication of translation of european patent specification

Ref document number: 1943240

Country of ref document: EP

Publication	Publication Date	Title
BRPI0714512A2 (pt)	2015-06-16	Compostos químicos
DK2089364T3 (da)	2013-09-02	Pyridinonforbindelser
FI20060288A0 (fi)	2006-03-27	Pinnoitusmenetelmä
EP1971595A4 (de)	2010-09-22	Cetp-inhibitoren
DE602007013995D1 (de)	2011-06-01	Beschichtungsverfahren
DK1860941T3 (da)	2009-03-02	Biphenyl-N-(4-pyridyl)methylsufonamider
EP1903334A4 (de)	2011-12-21	Biosensor
DE602007013849D1 (de)	2011-05-26	Mikroreaktor
DE602006002419D1 (de)	2008-10-09	Eintauchverfahren
DE602005006185D1 (de)	2008-06-05	Entwicklungsverfahren
DE602005019778D1 (de)	2010-04-15	Chemisches verfahren und produktionseinheit
ATE442898T1 (de)	2009-10-15	Filtrationsverfahren
EP1909098A4 (de)	2010-08-11	Biosensor
BRPI0618203A2 (pt)	2016-11-16	aparelho de revestimento
DE602006009980D1 (de)	2009-12-10	Biosensor
FI20065363A0 (fi)	2006-05-30	Erotusmenetelmä
DE602006012689D1 (de)	2010-04-15	Überprüfungsverfahren
ATE448218T1 (de)	2009-11-15	Chemisches verfahren
EP1860185A4 (de)	2009-08-12	Screening-verfahren
EP1951053A4 (de)	2010-12-01	Cetp-inhibitoren
EP1997902A4 (de)	2009-11-11	Screening-verfahren
DK1955066T3 (da)	2014-05-05	Membran-assay-fremgangsmåde
DK1962960T3 (da)	2013-08-26	Fremgangsmåde til mikornisering
FI20050208L (fi)	2006-10-09	Menetelmä uusien tuotteiden valmistamiseksi
DE602006004709D1 (de)	2009-02-26	Beschichtungsverfahren